4//SEC Filing
Saks Samuel R 4
Accession 0001615774-18-001756
CIK 0001430306other
Filed
Mar 8, 7:00 PM ET
Accepted
Mar 9, 3:36 PM ET
Size
14.7 KB
Accession
0001615774-18-001756
Insider Transaction Report
Form 4
Saks Samuel R
Director
Transactions
- Exercise/Conversion
Common Stock, $0.001 par value
2016-02-25+600→ 3,855 total - Exercise/Conversion
Restricted Stock Units
2017-02-09−750→ 0 total→ Common Stock (750 underlying) - Exercise/Conversion
Restricted Stock Units
2017-05-27−750→ 0 total→ Common Stock (750 underlying) - Exercise/Conversion
Common Stock, $0.001 par value
2017-05-27+750→ 6,605 total - Exercise/Conversion
Common Stock, $0.001 par value
2017-02-09+750→ 5,855 total - Exercise/Conversion
Restricted Stock Units
2016-02-25−650→ 0 total→ Common Stock (600 underlying)
Footnotes (4)
- [F1]Restricted stock units convert into common stock on a one-for-one basis.
- [F2]On May 27, 2016, the reporting person was granted 750 restricted stock units, vesting in on the first anniversary of the grant date.
- [F3]On February 9, 2016, the reporting person was granted 750 restricted stock units, vesting in on the first anniversary of the grant date.
- [F4]On February 25, 2015, the reporting person was granted 600 restricted stock units, vesting in on the first anniversary of the grant date.
Documents
Issuer
Tonix Pharmaceuticals Holding Corp.
CIK 0001430306
Entity typeother
Related Parties
1- filerCIK 0001365615
Filing Metadata
- Form type
- 4
- Filed
- Mar 8, 7:00 PM ET
- Accepted
- Mar 9, 3:36 PM ET
- Size
- 14.7 KB